Kestra Medical Technologies (NASDAQ:KMTS) Shares Up 4.6% – What’s Next?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s share price rose 4.6% during mid-day trading on Monday . The company traded as high as $15.84 and last traded at $15.72. Approximately 189,995 shares traded hands during mid-day trading, a decline of 8% from the average daily volume of 206,986 shares. The stock had previously closed at $15.03.

Analysts Set New Price Targets

A number of research firms have recently commented on KMTS. Bank of America assumed coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They issued a “buy” rating and a $30.00 price objective for the company. Wolfe Research initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “outperform” rating and a $29.00 price target for the company. Wells Fargo & Company started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued an “overweight” rating and a $28.00 price objective on the stock. The Goldman Sachs Group dropped their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a “neutral” rating for the company in a research note on Wednesday, April 16th. Finally, Piper Sandler started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued an “overweight” rating and a $27.00 target price on the stock. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, Kestra Medical Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $27.50.

Kestra Medical Technologies Trading Up 2.9%

The company has a fifty day simple moving average of $21.96.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its quarterly earnings results on Monday, April 14th. The company reported ($1.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same period in the previous year, the company earned ($1.18) earnings per share.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Brown Advisory Inc. bought a new stake in shares of Kestra Medical Technologies in the 1st quarter worth approximately $13,716,000. Caas Capital Management LP bought a new stake in Kestra Medical Technologies in the first quarter worth $1,470,000. Jennison Associates LLC purchased a new stake in Kestra Medical Technologies during the first quarter valued at about $1,869,000. TD Asset Management Inc bought a new position in shares of Kestra Medical Technologies during the first quarter valued at about $2,306,000. Finally, Federated Hermes Inc. purchased a new position in shares of Kestra Medical Technologies in the first quarter worth about $9,968,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.